Marina Podesta

Medicine & Life Sciences

1. Bone Marrow 100%
2. Leukemia, Myelogenous, Chronic, BCR-ABL Positive 95%
3. Aplastic Anaemia 72%
4. Stem Cells 71%
5. Blood Cells 58%
6. Fetal Blood 53%
7. Bone Marrow Transplantation 50%
8. Transplantation 49%
9. T-Lymphocytes 41%
10. Transplants 40%
11. Mesenchymal Stem Cells 37%
12. Tissue Donors 34%
13. Homologous Transplantation 28%
14. Hematopoietic Stem Cells 27%
15. In Vitro Techniques 27%
16. Cyclic ADP-Ribose 26%
17. Antilymphocyte Serum 23%
18. Bone Marrow Cells 23%
19. Autologous Transplantation 21%
20. Philadelphia Chromosome 19%
21. Hematopoiesis 19%
22. Growth 19%
23. Graft vs Host Disease 18%
24. Granulocyte-Macrophage Progenitor Cells 18%
25. Cell Culture Techniques 18%
26. Cyclosporine 17%
27. Granulocyte Colony-Stimulating Factor 17%
28. Lymphocytes 16%
29. Drug Therapy 16%
30. Erythroid Precursor Cells 15%
31. Leukapheresis 15%
32. Neuroblastoma 14%
33. Granulocytes 14%
34. Immunosuppressive Agents 14%
35. Leukemia 14%
36. Mitogens 13%
37. Survival 13%
38. Exosomes 13%
39. Pokeweed Mitogens 13%
40. Idarubicin 13%
41. Immunosuppression 13%
42. Cytogenetics 12%
43. Therapeutics 12%
44. Allogeneic Cells 11%
45. Cell Differentiation 11%
46. Precursor Cell Lymphoblastic Leukemia-Lymphoma 10%
47. Stem Cell Transplantation 10%
48. Myeloid Progenitor Cells 10%
49. Extracellular Vesicles 10%
50. Methylprednisolone 9%